These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18297309)
1. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep. El-Banna HA; Goudah A; El-Zorba H; Abd-El-Rahman S Parasitol Res; 2008 May; 102(6):1337-42. PubMed ID: 18297309 [TBL] [Abstract][Full Text] [Related]
2. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds. Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381 [TBL] [Abstract][Full Text] [Related]
3. Bioequivalence of ivermectin formulations in pigs and cattle. Lifschitz A; Pis A; Alvarez L; Virkel G; Sanchez S; Sallovitz J; Kujanek R; Lanusse C J Vet Pharmacol Ther; 1999 Feb; 22(1):27-34. PubMed ID: 10211714 [TBL] [Abstract][Full Text] [Related]
4. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. Lanusse C; Lifschitz A; Virkel G; Alvarez L; Sánchez S; Sutra JF; Galtier P; Alvinerie M J Vet Pharmacol Ther; 1997 Apr; 20(2):91-9. PubMed ID: 9131534 [TBL] [Abstract][Full Text] [Related]
5. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Lifschitz A; Virkel G; Pis A; Imperiale F; Sanchez S; Alvarez L; Kujanek R; Lanusse C Vet Parasitol; 1999 Oct; 86(3):203-15. PubMed ID: 10511102 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the long-acting ivermectin formulation in sheep: Further insight into potential pharmacokinetic interactions. Ballent M; Maté ML; Dominguez P; Virkel G; Albérich M; Lespine A; Lanusse C; Lifschitz AL J Vet Pharmacol Ther; 2019 Mar; 42(2):189-196. PubMed ID: 30520071 [TBL] [Abstract][Full Text] [Related]
7. Differences in the oral bioavailability of three rafoxanide formulations in sheep. Swan GE; Botha CJ; Taylor JH; Mülders MS; Minnaar PP; Kloeck A J S Afr Vet Assoc; 1995 Dec; 66(4):197-201. PubMed ID: 8691406 [TBL] [Abstract][Full Text] [Related]
8. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs. Gokbulut C; Karademir U; Boyacioglu M; McKellar QA Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198 [TBL] [Abstract][Full Text] [Related]
9. The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep. Barber S; Bowles V; Lespine A; Alvinerie M J Vet Pharmacol Ther; 2003 Oct; 26(5):343-8. PubMed ID: 14633186 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ivermectin in zebu Gobra (Bos indicus). Ndong TB; Kane Y; Ba MA; Sane I; Sutra JF; Alvinerie M Vet Parasitol; 2005 Mar; 128(1-2):169-73. PubMed ID: 15725548 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic evaluation of four ivermectin generic formulations in calves. Lifschitz A; Sallovitz J; Imperiale F; Pis A; Jauregui Lorda J; Lanusse C Vet Parasitol; 2004 Jan; 119(2-3):247-57. PubMed ID: 14746983 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics of moxidectin (Equest) and ivermectin (Eqvalan) in horses. Pérez R; Cabezas I; García M; Rubilar L; Sutra JF; Galtier P; Alvinerie M J Vet Pharmacol Ther; 1999 Jun; 22(3):174-80. PubMed ID: 10447828 [TBL] [Abstract][Full Text] [Related]
13. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations. Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559 [TBL] [Abstract][Full Text] [Related]
14. A comparative kinetic study of ivermectin and moxidectin in lactating camels (Camelus dromedarius). Oukessou M; Berrag B; Alvinerie M Vet Parasitol; 1999 Jun; 83(2):151-9. PubMed ID: 10392970 [TBL] [Abstract][Full Text] [Related]
15. Ivermectin environmental impact: Excretion profile in sheep and phytotoxic effect in Sinapis alba. Vokřál I; Michaela Š; Radka P; Jiří L; Lukáš P; Dominika S; Kateřina L; Barbora S; Lenka S Ecotoxicol Environ Saf; 2019 Mar; 169():944-949. PubMed ID: 30597795 [TBL] [Abstract][Full Text] [Related]
16. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Lifschitz A; Virkel G; Sallovitz J; Sutra JF; Galtier P; Alvinerie M; Lanusse C Vet Parasitol; 2000 Feb; 87(4):327-38. PubMed ID: 10669102 [TBL] [Abstract][Full Text] [Related]
17. Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep. Swan GE; Koeleman HA; Steyn HS; Mülders MS J S Afr Vet Assoc; 1999 Jun; 70(2):71-4. PubMed ID: 10855825 [TBL] [Abstract][Full Text] [Related]
18. Integrated assessment of ivermectin pharmacokinetics, efficacy against resistant Haemonchus contortus and P-glycoprotein expression in lambs treated at three different dosage levels. Alvarez L; Suarez G; Ceballos L; Moreno L; Canton C; Lifschitz A; Maté L; Ballent M; Virkel G; Lanusse C Vet Parasitol; 2015 May; 210(1-2):53-63. PubMed ID: 25841863 [TBL] [Abstract][Full Text] [Related]
19. Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep. Swan GE; Koeleman HA; Steyn HS; Mülders MS J S Afr Vet Assoc; 1999 Jun; 70(2):75-9. PubMed ID: 10855826 [TBL] [Abstract][Full Text] [Related]
20. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves. Vercruysse J; Deprez P; Everaert D; Bassissi F; Alvinerie M Vet Parasitol; 2008 Mar; 152(1-2):136-40. PubMed ID: 18207642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]